McKesson (MCK) Competitors

$736.60 +1.91 (+0.26%)

Closing price 05/13/2026 03:59 PM Eastern

Extended Trading

$737.05 +0.45 (+0.06%)

As of 09:13 AM Eastern

MCK vs. DXCM, HQY, HSIC, MMSI, and AMN

Should you buy McKesson stock or one of its competitors? MarketBeat compares McKesson with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with McKesson include DexCom (DXCM), HealthEquity (HQY), Henry Schein (HSIC), Merit Medical Systems (MMSI), and AMN Healthcare Services (AMN). These companies are all part of the "medical" sector.

How does McKesson compare to DexCom?

McKesson (NYSE:MCK) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

In the previous week, McKesson had 29 more articles in the media than DexCom. MarketBeat recorded 47 mentions for McKesson and 18 mentions for DexCom. DexCom's average media sentiment score of 1.22 beat McKesson's score of 0.84 indicating that DexCom is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	24 Very Positive mention(s)	7 Positive mention(s)	9 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive
DexCom	9 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

McKesson has higher revenue and earnings than DexCom. McKesson is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.22	$4.76B	$38.47	19.15
DexCom	$4.66B	4.85	$836.30M	$2.34	25.03

85.1% of McKesson shares are held by institutional investors. Comparatively, 97.8% of DexCom shares are held by institutional investors. 0.1% of McKesson shares are held by insiders. Comparatively, 0.3% of DexCom shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

McKesson presently has a consensus target price of $963.20, suggesting a potential upside of 30.76%. DexCom has a consensus target price of $83.22, suggesting a potential upside of 42.08%. Given DexCom's stronger consensus rating and higher possible upside, analysts clearly believe DexCom is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82
DexCom	1 Sell rating(s)	3 Hold rating(s)	18 Buy rating(s)	3 Strong Buy rating(s)	2.92

DexCom has a net margin of 19.31% compared to McKesson's net margin of 1.18%. DexCom's return on equity of 33.33% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.18%	-345.35%	5.85%
DexCom	19.31%	33.33%	13.19%

McKesson has a beta of 0.35, indicating that its stock price is 65% less volatile than the broader market. Comparatively, DexCom has a beta of 1.4, indicating that its stock price is 40% more volatile than the broader market.

Summary

DexCom beats McKesson on 13 of the 17 factors compared between the two stocks.

How does McKesson compare to HealthEquity?

McKesson (NYSE:MCK) and HealthEquity (NASDAQ:HQY) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

In the previous week, McKesson had 41 more articles in the media than HealthEquity. MarketBeat recorded 47 mentions for McKesson and 6 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.36 beat McKesson's score of 0.84 indicating that HealthEquity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	24 Very Positive mention(s)	7 Positive mention(s)	9 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthEquity	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

85.1% of McKesson shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 0.1% of McKesson shares are held by insiders. Comparatively, 1.5% of HealthEquity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

McKesson has a beta of 0.35, indicating that its stock price is 65% less volatile than the broader market. Comparatively, HealthEquity has a beta of 0.19, indicating that its stock price is 81% less volatile than the broader market.

HealthEquity has a net margin of 16.39% compared to McKesson's net margin of 1.18%. HealthEquity's return on equity of 13.86% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.18%	-345.35%	5.85%
HealthEquity	16.39%	13.86%	8.67%

McKesson has higher revenue and earnings than HealthEquity. McKesson is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.22	$4.76B	$38.47	19.15
HealthEquity	$1.31B	5.29	$215.20M	$2.46	33.41

McKesson presently has a consensus target price of $963.20, suggesting a potential upside of 30.76%. HealthEquity has a consensus target price of $111.79, suggesting a potential upside of 36.03%. Given HealthEquity's stronger consensus rating and higher possible upside, analysts clearly believe HealthEquity is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.87

Summary

HealthEquity beats McKesson on 11 of the 17 factors compared between the two stocks.

How does McKesson compare to Henry Schein?

Henry Schein (NASDAQ:HSIC) and McKesson (NYSE:MCK) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends.

Henry Schein presently has a consensus target price of $86.83, suggesting a potential upside of 25.03%. McKesson has a consensus target price of $963.20, suggesting a potential upside of 30.76%. Given McKesson's stronger consensus rating and higher possible upside, analysts clearly believe McKesson is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82

McKesson has higher revenue and earnings than Henry Schein. McKesson is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.38B	0.59	$398M	$3.31	20.98
McKesson	$403.43B	0.22	$4.76B	$38.47	19.15

Henry Schein has a net margin of 2.95% compared to McKesson's net margin of 1.18%. Henry Schein's return on equity of 15.44% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.95%	15.44%	5.53%
McKesson	1.18%	-345.35%	5.85%

96.6% of Henry Schein shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 0.9% of Henry Schein shares are held by company insiders. Comparatively, 0.1% of McKesson shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Henry Schein has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market. Comparatively, McKesson has a beta of 0.35, indicating that its stock price is 65% less volatile than the broader market.

In the previous week, McKesson had 36 more articles in the media than Henry Schein. MarketBeat recorded 47 mentions for McKesson and 11 mentions for Henry Schein. Henry Schein's average media sentiment score of 0.91 beat McKesson's score of 0.84 indicating that Henry Schein is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	5 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
McKesson	24 Very Positive mention(s)	7 Positive mention(s)	9 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Henry Schein and McKesson tied by winning 8 of the 16 factors compared between the two stocks.

How does McKesson compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and McKesson (NYSE:MCK) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends.

Merit Medical Systems presently has a consensus target price of $92.80, suggesting a potential upside of 48.20%. McKesson has a consensus target price of $963.20, suggesting a potential upside of 30.76%. Given Merit Medical Systems' higher possible upside, equities analysts clearly believe Merit Medical Systems is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82

McKesson has higher revenue and earnings than Merit Medical Systems. McKesson is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.54B	2.42	$128.49M	$2.31	27.11
McKesson	$403.43B	0.22	$4.76B	$38.47	19.15

Merit Medical Systems has a net margin of 9.03% compared to McKesson's net margin of 1.18%. Merit Medical Systems' return on equity of 13.54% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.03%	13.54%	7.94%
McKesson	1.18%	-345.35%	5.85%

99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 0.7% of Merit Medical Systems shares are held by company insiders. Comparatively, 0.1% of McKesson shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Merit Medical Systems has a beta of 0.58, indicating that its stock price is 42% less volatile than the broader market. Comparatively, McKesson has a beta of 0.35, indicating that its stock price is 65% less volatile than the broader market.

In the previous week, McKesson had 35 more articles in the media than Merit Medical Systems. MarketBeat recorded 47 mentions for McKesson and 12 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.03 beat McKesson's score of 0.84 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	5 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
McKesson	24 Very Positive mention(s)	7 Positive mention(s)	9 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Merit Medical Systems beats McKesson on 10 of the 16 factors compared between the two stocks.

How does McKesson compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and McKesson (NYSE:MCK) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability.

McKesson has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.44	-$95.70M	-$0.87	N/A
McKesson	$403.43B	0.22	$4.76B	$38.47	19.15

AMN Healthcare Services currently has a consensus target price of $25.29, suggesting a potential downside of 17.97%. McKesson has a consensus target price of $963.20, suggesting a potential upside of 30.76%. Given McKesson's stronger consensus rating and higher probable upside, analysts plainly believe McKesson is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.44
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82

McKesson has a net margin of 1.18% compared to AMN Healthcare Services' net margin of -0.95%. AMN Healthcare Services' return on equity of 18.01% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	-0.95%	18.01%	5.19%
McKesson	1.18%	-345.35%	5.85%

AMN Healthcare Services has a beta of 0.3, suggesting that its share price is 70% less volatile than the broader market. Comparatively, McKesson has a beta of 0.35, suggesting that its share price is 65% less volatile than the broader market.

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by company insiders. Comparatively, 0.1% of McKesson shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, McKesson had 25 more articles in the media than AMN Healthcare Services. MarketBeat recorded 47 mentions for McKesson and 22 mentions for AMN Healthcare Services. McKesson's average media sentiment score of 0.84 beat AMN Healthcare Services' score of 0.56 indicating that McKesson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	4 Very Positive mention(s)	4 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
McKesson	24 Very Positive mention(s)	7 Positive mention(s)	9 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

McKesson beats AMN Healthcare Services on 12 of the 17 factors compared between the two stocks.

Get McKesson News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MCK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MCK vs. The Competition

Export

Metric	McKesson	MED/DENTAL Industry	Medical Sector	NYSE Exchange
Market Cap	$88.31B	$14.76B	$6.31B	$22.97B
Dividend Yield	0.45%	2.08%	2.79%	4.07%
P/E Ratio	19.15	17.30	21.03	28.29
Price / Sales	0.22	2.12	551.42	24.60
Price / Cash	16.12	12.42	42.94	25.11
Price / Book	-49.84	2.95	9.76	4.73
Net Income	$4.76B	$534.24M	$3.55B	$1.07B
7 Day Performance	-2.23%	1.96%	-0.53%	-1.11%
1 Month Performance	-14.62%	-1.51%	1.20%	1.36%
1 Year Performance	7.97%	-4.66%	41.21%	24.41%

McKesson Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MCK McKesson	4.9228 of 5 stars	$736.60 +0.3%	$963.20 +30.8%	+7.1%	$88.31B	$403.43B	19.15	45,000	Earnings Report Analyst Forecast
DXCM DexCom	4.7163 of 5 stars	$60.04 -2.1%	$83.50 +39.1%	-30.4%	$23.17B	$4.82B	25.66	11,000	Analyst Upgrade
HQY HealthEquity	4.2021 of 5 stars	$82.18 -0.3%	$111.79 +36.0%	-15.3%	$6.94B	$1.31B	33.41	2,814	Positive News
HSIC Henry Schein	4.2633 of 5 stars	$72.02 -2.6%	$87.75 +21.8%	-1.5%	$8.26B	$13.18B	22.02	25,000	Insider Trade
MMSI Merit Medical Systems	4.1018 of 5 stars	$62.01 flat	$92.80 +49.7%	-35.8%	$3.70B	$1.52B	26.84	7,500	Positive News Insider Trade High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MCK) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

McKesson (MCK) Competitors

MCK vs. DXCM, HQY, HSIC, MMSI, and AMN

How does McKesson compare to DexCom?

Summary

How does McKesson compare to HealthEquity?

Summary

How does McKesson compare to Henry Schein?

Summary

How does McKesson compare to Merit Medical Systems?

Summary

How does McKesson compare to AMN Healthcare Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCK vs. The Competition

McKesson Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

McKesson (MCK) Competitors

MCK vs. DXCM, HQY, HSIC, MMSI, and AMN

How does McKesson compare to DexCom?

Does the media prefer MCK or DXCM?

Which has better earnings & valuation, MCK or DXCM?

Do institutionals & insiders hold more shares of MCK or DXCM?

Do analysts rate MCK or DXCM?

Is MCK or DXCM more profitable?

Which has more risk and volatility, MCK or DXCM?

Summary

How does McKesson compare to HealthEquity?

Does the media prefer MCK or HQY?

Do institutionals & insiders hold more shares of MCK or HQY?

Which has more risk and volatility, MCK or HQY?

Is MCK or HQY more profitable?

Which has better earnings & valuation, MCK or HQY?

Do analysts rate MCK or HQY?

Summary

How does McKesson compare to Henry Schein?

Do analysts rate HSIC or MCK?

Which has stronger earnings & valuation, HSIC or MCK?

Is HSIC or MCK more profitable?

Do insiders & institutionals hold more shares of HSIC or MCK?

Which has more risk and volatility, HSIC or MCK?

Does the media favor HSIC or MCK?

Summary

How does McKesson compare to Merit Medical Systems?

Do analysts rate MMSI or MCK?

Which has stronger earnings & valuation, MMSI or MCK?

Is MMSI or MCK more profitable?

Do insiders & institutionals hold more shares of MMSI or MCK?

Which has more risk and volatility, MMSI or MCK?

Does the media favor MMSI or MCK?

Summary

How does McKesson compare to AMN Healthcare Services?

Which has higher earnings & valuation, AMN or MCK?

Do analysts prefer AMN or MCK?

Is AMN or MCK more profitable?

Which has more volatility and risk, AMN or MCK?

Do institutionals & insiders hold more shares of AMN or MCK?

Does the media favor AMN or MCK?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCK vs. The Competition

McKesson Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools